KEVIN R. SAYER - 14 Feb 2022 Form 4 Insider Report for DEXCOM INC (DXCM)

Role
Chairman, CEO & President, Director
Signature
By: Jereme Sylvain For: Kevin R Sayer
Issuer symbol
DXCM
Transactions as of
14 Feb 2022
Transactions value $
-$1,254,120
Form type
4
Filing time
15 Feb 2022, 19:09:16 UTC
Previous filing
20 Jan 2022
Next filing
10 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXCM Common Stock Sale -$1.25M -3K -3.07% $418.04 94.6K 14 Feb 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On July 31, 2020, Mr. Sayer adopted a 10b5-1 Plan, which was amended effective June 15, 2021. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan.
F2 Included in this number are 36,385 unvested restricted stock units, 13,445 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,968 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 5,972 of which were granted on March 8, 2019 and shall vest through March 8, 2022.